RadTran

RadTran is a radiopharmaceutical company focused on the development and supply of high-purity alpha-emitting isotopes for cancer treatment. Based in Oak Ridge, Tennessee, the company utilizes proprietary separation and purification technologies to produce medical-grade isotopes such as Actinium-225 and Lead-212. These isotopes are essential for Targeted Alpha Therapy (TAT), a modality that delivers high-energy radiation directly to tumor cells with minimal impact on surrounding healthy tissue. RadTran's mission is to alleviate the global supply constraints of these rare isotopes, enabling the advancement of clinical research and the commercialization of next-generation oncology therapies. The company maintains strong ties with the Oak Ridge National Laboratory to leverage world-class nuclear science expertise.